The aim is to explore the therapeutic potential of liposome@azoramide in cancer treatment by targeting mitochondrial metabolism.
Evaluated the effects of liposome@azoramide on cancer cells
Analyzed mitochondrial metabolic pathways
Assessing cellular responses to therapeutic intervention
Liposome@azoramide significantly suppresses oxidative phosphorylation in cancer cells
Demonstrated potential to selectively target cancer metabolism
Highlights new therapeutic strategies in oncology
Abstract
Overall, our findings suggest that Lip@Azo is a promising strategy for targeting mitochondrial metabolism in cancer, offering a new avenue for therapeutic development in oncology.